{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:17Z","timestamp":1760144297137,"version":"build-2065373602"},"reference-count":92,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"am","delay-in-days":395,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.rmr.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:40:02Z","timestamp":1697539202000},"page":"768-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Maladie associ\u00e9e aux IgG4\u00a0: une maladie prot\u00e9iforme aux manifestations thoraciques fr\u00e9quentes"],"prefix":"10.1016","volume":"40","author":[{"given":"M.","family":"Groh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Habert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ebbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gaigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Y.","family":"Gaubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Schleinitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2023.10.001_bib0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease\u00a0: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2023.10.001_bib0470","doi-asserted-by":"crossref","first-page":"m1067","DOI":"10.1136\/bmj.m1067","article-title":"Advances in the diagnosis and management of IgG4\u00a0related disease","volume":"369","author":"Lanzillotta","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.rmr.2023.10.001_bib0475","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0480","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF02232341","article-title":"Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease?","volume":"6","author":"Sarles","year":"1961","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0485","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/BF02285209","article-title":"Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis","volume":"40","author":"Yoshida","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rmr.2023.10.001_bib0490","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4\u00a0concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0495","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00006676-200408000-00014","article-title":"IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis","volume":"29","author":"Kamisawa","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.rmr.2023.10.001_bib0500","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2023.10.001_bib0505","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0510","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.rmr.2023.10.001_bib0515","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0520","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for diagnostic criteria for IgG4-related kidney disease","volume":"15","author":"Kawano","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0525","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-related tubulointerstitial nephritis","volume":"22","author":"Raissian","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0530","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0535","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019\u00a0American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0540","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.2002.33022","article-title":"HLA DRB10405-DQB10401\u00a0haplotype is associated with autoimmune pancreatitis in the Japanese population","volume":"122","author":"Kawa","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rmr.2023.10.001_bib0545","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1572-0241.2007.01750.x","article-title":"Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4\u00a0gene polymorphisms in Japanese patients","volume":"103","author":"Umemura","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0550","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/gut.2006.095059","article-title":"Genetic association of Fc receptor-like 3\u00a0polymorphisms with autoimmune pancreatitis in Japanese patients","volume":"55","author":"Umemura","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.rmr.2023.10.001_bib0555","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1155\/2011\/264747","article-title":"Polymorphism in the KCNA3\u00a0gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population","volume":"31","author":"Ota","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.rmr.2023.10.001_bib0560","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M13-2648","article-title":"Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study","volume":"161","author":"Goldoni","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0565","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1093\/rheumatology\/keab172","article-title":"The association of smoking with immunoglobulin G4-related disease: a case-control study","volume":"60","author":"Wallwork","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmr.2023.10.001_bib0570","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4\u00a0concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0575","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-021-02481-3","article-title":"Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study","volume":"23","author":"Peng","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rmr.2023.10.001_bib0580","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","article-title":"Enhanced IgG4\u00a0production by follicular helper 2\u00a0T cells and the involvement of follicular helper 1\u00a0T cells in the pathogenesis of IgG4-related disease","volume":"18","author":"Akiyama","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rmr.2023.10.001_bib0585","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2017.00235","article-title":"T Cell Polarization toward TH2\/TFH2\u00a0and TH17\/TFH17\u00a0in Patients with IgG4-Related Disease","volume":"8","author":"Grados","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0590","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","article-title":"Preferential M2\u00a0macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"156","author":"Furukawa","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0600","first-page":"1038","article-title":"Role of eosinophilia in IgG4-related disease","volume":"40","author":"Ming","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0605","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3\u00a0as an autoantigen in patients with IgG(4)-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0610","doi-asserted-by":"crossref","first-page":"eaaq0997","DOI":"10.1126\/scitranslmed.aaq0997","article-title":"Laminin 511\u00a0is a target antigen in autoimmune pancreatitis","volume":"10","author":"Shiokawa","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0615","first-page":"728","article-title":"Annexin A11\u00a0is targeted by IgG4\u00a0and IgG1\u00a0autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.rmr.2023.10.001_bib0620","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0625","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/03009742.2013.822094","article-title":"IgG4-related disease in a Chinese cohort: a prospective study","volume":"43","author":"Chen","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0630","doi-asserted-by":"crossref","first-page":"103035","DOI":"10.1016\/j.autrev.2022.103035","article-title":"A descriptive study of IgG4-related disease in children and young adults","volume":"21","author":"de Sainte Marie","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rmr.2023.10.001_bib0635","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/MPA.0b013e3182480c99","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan","volume":"41","author":"Kanno","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.rmr.2023.10.001_bib0640","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s00535-020-01704-9","article-title":"Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019","volume":"55","author":"Masamune","year":"2020","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0645","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/ard-2023-223950","article-title":"Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults","volume":"82","author":"Wallace","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0650","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/2050640620934911","article-title":"European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"L\u00f6hr","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.rmr.2023.10.001_bib0655","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/ejh.12842","article-title":"IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: a comparative case series","volume":"98","author":"Carruthers","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0660","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4\u00a0immune response in Churg-Strauss syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0665","doi-asserted-by":"crossref","first-page":"602809","DOI":"10.1155\/2012\/602809","article-title":"Pathologies associated with serum IgG4\u00a0elevation","volume":"2012","author":"Ebbo","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0670","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2016.01.014","article-title":"What are the characteristics of asthma patients with elevated serum IgG4\u00a0levels?","volume":"112","author":"Flament","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0675","doi-asserted-by":"crossref","first-page":"e3785","DOI":"10.1097\/MD.0000000000003785","article-title":"Diagnostic Value of Serum IgG4\u00a0for IgG4-Related Disease: A PRISMA-compliant Systematic Review and Meta-analysis","volume":"95","author":"Hao","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2023.10.001_bib0680","first-page":"408","article-title":"The positive predictive value of a very high serum IgG4\u00a0concentration for the diagnosis of IgG4-related disease","volume":"50","author":"Baker","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0685","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","article-title":"New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334\u00a0cases","volume":"19","author":"Yamada","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rmr.2023.10.001_bib0690","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0695","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/art.39686","article-title":"IgG4-related disease: retrospective analysis of one hundred sixty-six patients","volume":"68","author":"Sekiguchi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0700","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0705","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2023.10.001_bib0710","doi-asserted-by":"crossref","first-page":"102889","DOI":"10.1016\/j.autrev.2021.102889","article-title":"IgG4-related disease and hypereosinophilic syndrome: overlapping phenotypes","volume":"20","author":"Moussiegt","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rmr.2023.10.001_bib0715","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2023.10.001_bib0720","doi-asserted-by":"crossref","first-page":"71","DOI":"10.55563\/clinexprheumatol\/qq9qup","article-title":"Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners","volume":"40","author":"Iaccarino","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0730","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rmr.2023.10.001_bib0735","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1183\/09031936.00025211","article-title":"Pulmonary manifestations of immunoglobulin G4-related sclerosing disease","volume":"39","author":"Ryu","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.10.001_bib0740","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2017.10.005","article-title":"Thoracic involvement in IgG4-related disease in a UK-based patient cohort","volume":"132","author":"Corcoran","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0745","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2019.06.010","article-title":"An update on IgG4-related lung disease","volume":"66","author":"Morales","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0750","doi-asserted-by":"crossref","first-page":"358371","DOI":"10.1155\/2012\/358371","article-title":"Prevalence of IgG4-related disease in japan based on Nationwide survey in 2009","volume":"2012","author":"Uchida","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0755","first-page":"30","article-title":"Thoracic involvement and imaging patterns in IgG4-related disease","author":"Muller","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmr.2023.10.001_bib0760","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejrad.2009.06.010","article-title":"Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis","volume":"76","author":"Fujinaga","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0765","doi-asserted-by":"crossref","first-page":"W99","DOI":"10.2214\/AJR.18.20834","article-title":"CT Findings of Thoracic Paravertebral Lesions in IgG4-Related Disease","volume":"213","author":"Inoue","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0770","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rmed.2017.09.006","article-title":"Clinical characterization of 52\u00a0patients with immunoglobulin G4-related disease in a single tertiary center in Japan: Special reference to lung disease in thoracic high-resolution computed tomography","volume":"132","author":"Saraya","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0775","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12931-020-01542-6","article-title":"Long-term clinical course and outcomes of immunoglobulin G4-related lung disease","volume":"21","author":"Kang","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.rmr.2023.10.001_bib0780","doi-asserted-by":"crossref","first-page":"e3344","DOI":"10.1097\/MD.0000000000003344","article-title":"Large vessel involvement by IgG4-related disease","volume":"95","author":"Perugino","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2023.10.001_bib0785","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1183\/09031936.00130314","article-title":"Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease","volume":"45","author":"Fukihara","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2023.10.001_bib0790","doi-asserted-by":"crossref","first-page":"e14437","DOI":"10.1097\/MD.0000000000014437","article-title":"Pulmonary vascular involvement of IgG4-related disease: case series with a PRISMA-compliant systemic review","volume":"98","author":"Zhou","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2023.10.001_bib0725","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019\u00a0American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0795","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0800","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/PAS.0b013e3181bd535b","article-title":"IgG4-related lung and pleural disease: a clinicopathologic study of 21\u00a0cases","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0805","doi-asserted-by":"crossref","first-page":"100765","DOI":"10.1016\/j.waojou.2023.100765","article-title":"Implication of allergy and atopy in IgG4-related disease","volume":"16","author":"D\u2019Astous-Gauthier","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.rmr.2023.10.001_bib0810","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-199809000-00001","article-title":"Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62\u00a0cases. The Groupe d\u2019Etudes et de Recherche sur les Maladies \u00ab\u00a0Orphelines\u00a0\u00bb Pulmonaires (GERM\u201cO\u201dP)","volume":"77","author":"Marchand","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2023.10.001_bib0815","doi-asserted-by":"crossref","first-page":"e1.1317","DOI":"10.1016\/j.jaip.2022.12.022","article-title":"Targeting IL-5\/5R for the treatment of idiopathic chronic eosinophilic pneumonia","volume":"11","author":"Delcros","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2023.10.001_bib0820","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.resinv.2015.09.002","article-title":"Proposed diagnostic criteria for IgG4-related respiratory disease","volume":"54","author":"Matsui","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.rmr.2023.10.001_bib0825","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/rheumatology\/kes358","article-title":"Necessity of early intervention for IgG4-related disease--delayed treatment induces fibrosis progression","volume":"52","author":"Shimizu","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmr.2023.10.001_bib0830","doi-asserted-by":"crossref","first-page":"103273","DOI":"10.1016\/j.autrev.2023.103273","article-title":"Development of an algorithm for IgG4-related disease management","volume":"22","author":"Orozco-G\u00e1lvez","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rmr.2023.10.001_bib0835","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2016.1259602","article-title":"A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease","volume":"27","author":"Masaki","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0840","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MPA.0000000000000044","article-title":"Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis","volume":"43","author":"Buijs","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.rmr.2023.10.001_bib0845","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00535-016-1302-1","article-title":"Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1\u00a0autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510\u00a0patients","volume":"52","author":"Kubota","year":"2017","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0850","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/key227","article-title":"Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial","volume":"58","author":"Yunyun","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmr.2023.10.001_bib0855","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","article-title":"Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids","volume":"7","author":"Yunyun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.rmr.2023.10.001_bib0860","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/ctg.2017.17","article-title":"Azathioprine maintenance therapy to prevent relapses in autoimmune pancreatitis","volume":"8","author":"de Pretis","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0865","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1080\/14397595.2018.1532560","article-title":"Effectiveness of tacrolimus on IgG4-related disease","volume":"29","author":"Takanashi","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0870","doi-asserted-by":"crossref","first-page":"831","DOI":"10.14309\/ajg.0000000000000232","article-title":"Methotrexate as induction of remission therapy for type 1\u00a0autoimmune pancreatitis","volume":"114","author":"Rovati","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0875","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/kez380","article-title":"Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis","volume":"59","author":"Omar","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmr.2023.10.001_bib0880","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejim.2019.12.029","article-title":"Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease","volume":"74","author":"Campochiaro","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rmr.2023.10.001_bib0885","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","article-title":"B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease","volume":"74","author":"Della-Torre","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0890","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0895","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmr.2023.10.001_bib0900","doi-asserted-by":"crossref","first-page":"259408","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD Responder Index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0905","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/acr.22058","article-title":"Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study","volume":"66","author":"Ebbo","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rmr.2023.10.001_bib0910","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2665-9913(21)00359-3","article-title":"Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study","volume":"4","author":"Matza","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.rmr.2023.10.001_bib0915","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1136\/annrheumdis-2020-217010","article-title":"Correspondence on: \u00ab\u00a0Dupilumab as a novel steroid-sparing treatment for IgG(4)-related disease\u00a0\u00bb by Simpson et al","volume":"81","author":"Ebbo","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rmr.2023.10.001_bib0460","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1016\/S2665-9913(23)00157-1","article-title":"Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2\u00a0pilot trial","volume":"5","author":"Perugino","year":"2023","journal-title":"Lancet Rheumatol"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842523002590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842523002590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:25:14Z","timestamp":1760106314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842523002590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":92,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0761842523002590"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2023.10.001","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladie associ\u00e9e aux IgG4\u00a0: une maladie prot\u00e9iforme aux manifestations thoraciques fr\u00e9quentes","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}